Ledger.Open graph →
SEC Form D · Amendment · filed April 9, 2014

CHRONIX BIOMEDICAL INC

Offering
$14.5M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN JOSE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Thomas H. Cardiff · Pittsburgh, PADirectorEric J. Wichterman · Phoenix, AZExecBehzad Aghazadeh · New York, NYExec · DirectorNeil S. Fineman · Las Vegas, NVDirectorSandip K. Agarwala · Cambridge, MADirectorAlan Weber · Armonk, NYDirectorScott Epstein · New York, NYDirectorCorbin J. Robertson Iii · Houston, TXDirectorMichael V. Oh, Md · Pittsburgh, PADirectorMark H. Fiskio · Newton, MADirectorCasey A. Fries · New York, NYDirectorVicky Schiff · CALABASAS, CAExec · DirectorEthan Penner · CALABASAS, CADirectorJereme Thaxton · Salt Lake City, UTExecDaniel Goodman · San Francisco, CADirectorAnurag Pal · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗